These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1226193)

  • 41. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatic changes in the neurological form of Wilson's disease].
    Hauftová D; Hartl J; Slavícek J; Valach V; Fialová J; Pojerová M
    Vnitr Lek; 1967 Nov; 13(11):1064-9. PubMed ID: 6081668
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of Wilson's disease.
    Richardson JC
    Mod Treat; 1968 Mar; 5(2):321-31. PubMed ID: 5655947
    [No Abstract]   [Full Text] [Related]  

  • 44. Transient external ophthalmoplegia in Wilson's disease.
    Gadoth N; Liel Y
    Metab Pediatr Ophthalmol; 1980; 4(2):71-2. PubMed ID: 7442347
    [No Abstract]   [Full Text] [Related]  

  • 45. [D-penicillamine and cutaneous lesions in Wilson's disease].
    Peiró Grasa A; Barnadas Andiñach M; Moreno Carazo A; Grau-Veciana JM
    Neurologia; 1986; 1(2):88-9. PubMed ID: 2978898
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of oral zinc therapy as an alternative to penicillamine for Wilson's disease.
    Cossack ZT
    N Engl J Med; 1988 Feb; 318(5):322-3. PubMed ID: 3336426
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
    Charlebois G; Cadotte M; Barbeau A
    Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapy and rehabilitation of Wilson's disease (author's transl)].
    Eichner B; Lössner J; Bachmann H; Diessner H; Biesold D; Günther K
    Folia Clin Int (Barc); 1974 Nov; 24(11):776-92. PubMed ID: 4435281
    [No Abstract]   [Full Text] [Related]  

  • 50. [Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
    Berio A; Vento R; Di Stefano A
    Minerva Pediatr; 1973 May; 25(18):807-13. PubMed ID: 4732090
    [No Abstract]   [Full Text] [Related]  

  • 51. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

  • 52. [Early detection and treatment of Wilson's disease].
    Sternlieb I
    Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):859-62. PubMed ID: 5834270
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease.
    Czlonkowska A
    Mater Med Pol; 1976; 8(1):48-50. PubMed ID: 1263584
    [No Abstract]   [Full Text] [Related]  

  • 54. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina].
    Escartín Marín P; García Plaza A; Chantar Barrios C
    Rev Clin Esp; 1974 Jun; 133(5):451-4. PubMed ID: 4215106
    [No Abstract]   [Full Text] [Related]  

  • 56. [Wilson's disease. Introduction to current problems (early diagnosis and therapy)].
    Wewalka F
    Wien Z Inn Med; 1967; 48(12):461-5. PubMed ID: 5620586
    [No Abstract]   [Full Text] [Related]  

  • 57. Glucose intolerance in Wilson's disease. Normalization after treatment with penicillamine.
    Johansen K; Gregersen G
    Arch Intern Med; 1972 Apr; 129(4):587-90. PubMed ID: 5019448
    [No Abstract]   [Full Text] [Related]  

  • 58. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
    López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
    Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
    Rosenberger K
    Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of Wilson's disease].
    Pépin B; Barraine R
    Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.